COMBINATIONS OF A SPECIFIC HCV NS5A INHIBITOR AND AN HCV NS3 PROTEASE INHIBITOR

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations. La presente invención se r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STACEY A. VOSS, SUSAN E. CHANIEWSKI, MIN GAO, AMY K. SHEAFFER, FIONA MCPHEE, JULIE A. LEMM
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit Hepatitis C virus (HCV), compositions comprising such compounds, and methods for treating Hepatitis C using such combinations. La presente invención se refiere en general a compuestos antivirales, y más específicamente se dirige a combinaciones de compuestos los cuales pueden inhibir el virus de la Hepatitis C (HCV), composiciones que comprenden tales compuestos, y métodos para tratar la Hepatitis C usando tales combinaciones.